Digestive & Intestinal Remedies (Pharmacies) - Lithuania

Lithuania

Highlights

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$26.94m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.96%, resulting in a market volume of US$34.32m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$10.01 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestive & Intestinal Remedies (Pharmacies) market in Lithuania has been experiencing steady growth in recent years. Customer preferences in the market are largely driven by the increasing awareness of digestive health and the desire for natural remedies. Consumers in Lithuania are becoming more conscious of their overall well-being and are seeking products that can help alleviate digestive issues. As a result, there is a growing demand for digestive and intestinal remedies that are made from natural ingredients and have fewer side effects. This trend is in line with the global shift towards natural and organic products in the healthcare industry. In addition, there is a rising prevalence of digestive disorders in Lithuania, which is also contributing to the growth of the market. Factors such as unhealthy diets, sedentary lifestyles, and high-stress levels are leading to an increase in digestive issues among the population. As a result, more people are turning to digestive and intestinal remedies to manage their symptoms and improve their overall digestive health. One of the key trends in the market is the increasing availability of digestive and intestinal remedies in pharmacies. Pharmacies in Lithuania are expanding their product offerings to cater to the growing demand for these remedies. They are stocking a wide range of products, including probiotics, antacids, and laxatives, to meet the diverse needs of consumers. This trend is driven by the convenience and accessibility of pharmacies, as well as the trust that consumers have in these establishments. Another trend in the market is the growing popularity of online pharmacies. With the rise of e-commerce, more consumers are purchasing digestive and intestinal remedies online. Online pharmacies offer a wide selection of products, competitive prices, and convenient delivery options, making it easier for consumers to access the remedies they need. This trend is expected to continue as more people embrace online shopping and seek the convenience of having products delivered to their doorstep. Local special circumstances in Lithuania also play a role in the development of the Digestive & Intestinal Remedies market. The country has a well-established healthcare system, which includes a network of pharmacies that provide easy access to over-the-counter remedies. This infrastructure supports the growth of the market by ensuring that consumers have convenient access to the products they need. Underlying macroeconomic factors, such as the increasing disposable income and improving living standards in Lithuania, are also driving the growth of the Digestive & Intestinal Remedies market. As people have more disposable income, they are willing to spend more on their health and well-being, including purchasing remedies for digestive issues. Additionally, the improving living standards in the country have led to a greater focus on preventive healthcare, which includes taking care of digestive health. In conclusion, the Digestive & Intestinal Remedies market in Lithuania is experiencing steady growth due to increasing customer preferences for natural remedies, rising prevalence of digestive disorders, and the availability of products in pharmacies and online. The local special circumstances, such as the well-established healthcare system, and underlying macroeconomic factors, including increasing disposable income and improving living standards, are further driving the market's development.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.